The overall goal of the proposed research is to understand the control of the elongation phase of transcription by RNA polymerase II. This control process is mediated by negative factors which cause RNA polymerase II to synthesize only short transcripts after initiation from a promoter and positive factors that allow release from this early block in elongation. A Drosophila in vitro system will be used to further characterize three factors that were recently identified as being involved in controlling this transition from abortive elongation into productive elongation. The C- terminal domain (CTD) of the large subunit of RNA polymerase II has been implicated in the control process and its role will be further examined. The function of P-TEFb as a CTD kinase operating during elongation will be defined. The involvement of factor 2 as a potential ATP dependent termination factor and as a factor required for the elongation control process will be examined. The role of P-TEFa and search for other factors that may be involved will be continued. Although the ultimate goal is to generate a defined system that mimics initiation and elongation control in vivo, the feasibility of using a simple defined elongation control system consisting of pure RNA polymerase II, a dC-tailed template, and a set of elongation control factors will be examined. It is vital to understand the elongation control process because it is involved in controlling a large number of genes including many oncogenes and viral transcription units including HIV-1. It is likely that the study of this controlling step in eucaryotic gene expression will lead to a better understanding of the aberrant behavior of cancer cells and the process that controls the transcription of the HIV-1 genome.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM035500-15
Application #
2900611
Study Section
Molecular Biology Study Section (MBY)
Program Officer
Tompkins, Laurie
Project Start
1989-01-01
Project End
2000-06-30
Budget Start
1999-04-01
Budget End
2000-06-30
Support Year
15
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Iowa
Department
Biochemistry
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Price, David H (2018) Transient pausing by RNA polymerase II. Proc Natl Acad Sci U S A 115:4810-4812
Nilson, Kyle A; Lawson, Christine K; Mullen, Nicholas J et al. (2017) Oxidative stress rapidly stabilizes promoter-proximal paused Pol II across the human genome. Nucleic Acids Res 45:11088-11105
Bosque, Alberto; Nilson, Kyle A; Macedo, Amanda B et al. (2017) Benzotriazoles Reactivate Latent HIV-1 through Inactivation of STAT5 SUMOylation. Cell Rep 18:1324-1334
Mullen, Nicholas J; Price, David H (2017) Hydrogen peroxide yields mechanistic insights into human mRNA capping enzyme function. PLoS One 12:e0186423
Brogie, John E; Price, David H (2017) Reconstitution of a functional 7SK snRNP. Nucleic Acids Res 45:6864-6880
Tan, Justin L; Fogley, Rachel D; Flynn, Ryan A et al. (2016) Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma. Mol Cell 62:34-46
Nilson, Kyle A; Guo, Jiannan; Turek, Michael E et al. (2015) THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing. Mol Cell 59:576-87
Guo, Jiannan; Li, Tiandao; Schipper, Joshua et al. (2014) Sequence specificity incompletely defines the genome-wide occupancy of Myc. Genome Biol 15:482
Fowler, Trent; Ghatak, Payel; Price, David H et al. (2014) Regulation of MYC expression and differential JQ1 sensitivity in cancer cells. PLoS One 9:e87003
Guo, Jiannan; Turek, Michael E; Price, David H (2014) Regulation of RNA polymerase II termination by phosphorylation of Gdown1. J Biol Chem 289:12657-65

Showing the most recent 10 out of 80 publications